{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T04:11:50Z","timestamp":1747455110363,"version":"3.40.5"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.thromres.2025.109338","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T23:27:58Z","timestamp":1746487678000},"page":"109338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prescribing preferences for reduced-dose direct oral anticoagulation for extended-phase venous thromboembolism treatment"],"prefix":"10.1016","volume":"250","author":[{"given":"Danielle","family":"Groat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karlyn A.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel P.","family":"Rosovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen M.","family":"Sanfilippo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manila","family":"Gaddh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa Baumann","family":"Kreuziger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Federici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott C.","family":"Woller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.thromres.2025.109338_bb0005","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","article-title":"Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest"},{"author":"ELIQUIS","key":"10.1016\/j.thromres.2025.109338_bb0010"},{"author":"XARELTO Package Insert","key":"10.1016\/j.thromres.2025.109338_bb0015"},{"issue":"8","key":"10.1016\/j.thromres.2025.109338_bb0020","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"Agnelli","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.thromres.2025.109338_bb0025","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMoa1700518","article-title":"Rivaroxaban or aspirin for extended treatment of venous thromboembolism","volume":"376","author":"Weitz","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.thromres.2025.109338_bb0030","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/jth.14156","article-title":"Reduced-dose direct oral anticoagulants in the extended treatment of venous thromboembolism: a systematic review and meta-analysis","volume":"16","author":"Vasanthamohan","year":"2018","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2025.109338_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12740","article-title":"Physician perceptions and use of reduced-dose direct oral anticoagulants for extended phase venous thromboembolism treatment","volume":"6","author":"Groat","year":"2022","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2025.109338_bb0040","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/jcm13010096","article-title":"Primary care clinicians\u2019 prescribing patterns of reduced-dose direct oral anticoagulants for extended-phase venous thromboembolism treatment","volume":"13","author":"Groat","year":"2024","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.thromres.2025.109338_bb0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11239-023-02893-9","article-title":"Digital dashboards for direct oral anticoagulant surveillance, intervention and operational efficiency: uptake, obstacles, and opportunities","volume":"57","author":"Triller","year":"2024","journal-title":"J. Thromb. Thrombolysis"},{"issue":"18","key":"10.1016\/j.thromres.2025.109338_bb0050","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.035859","article-title":"Pharmacist use of a population management dashboard for safe anticoagulant prescribing: evaluation of a nationwide implementation effort","volume":"13","author":"Barnes","year":"2024","journal-title":"J. Am. Heart Assoc."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825000878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825000878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T16:58:47Z","timestamp":1747414727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825000878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":10,"alternative-id":["S0049384825000878"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109338","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prescribing preferences for reduced-dose direct oral anticoagulation for extended-phase venous thromboembolism treatment","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109338","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109338"}}